GB2153867A

GB2153867A - Wrapped radio opaque yarn

Info

Publication number: GB2153867A
Application number: GB08430257A
Authority: GB
Inventors: Dr Edmund Carus
Original assignee: Vernon Carus Ltd
Current assignee: Vernon Carus Ltd
Priority date: 1984-02-11
Filing date: 1984-11-30
Publication date: 1985-08-29
Also published as: EP0154423A1; ATE33997T1; EP0154423B1; GB2153867B; DE3562494D1; GB8430257D0; CA1262815A; CA1262815C; GB8403656D0

Abstract

A radio opaque yarn comprises a bundle of filled polypropylene fibres containing 54% to 80% <w>/w of barium sulphate, the bundle being bound with up to 20% <w>/w of substantially unfilled polyester fibres.

Description

1 GB 2 153 867A 1

SPECIFICATION

Wrapped radio opaque yarn This invention relates to radio opaque yarn 70 such as that used in the manufacture of surgical swabs and dressings.

Radio opaque fibres are disclosed in our European patent application No.

83304777.2. These fibres contain a high 75 proportion of barium sulphate in order to provide the required degree of X-ray opacity.

Such highly filled fibres tend to stretch due to fracture of the constituent filaments. Moreover the fractured filaments tend to run causing aggregations which may snarl- up during weaving.

According to the present invention a radio opaque yarn comprises a bundle of filled fibres containing not less that 54% w/w of barium sulphate, the bundle being bound with up to 20% w/w of substantially unfilled binding fibre.

Conventional wrapped yarns contain ap- proximately 50% by weight of binding fibre. The present invention employs a higher proportion of filled fibres. This is important in the production of radio opaque yarns to optimise the opacity of the product. The unfilled, bind- ing fibre may have a higher modulus and tensile strength than the filled fibres, increasing the strength and durability of the yarn. Furthermore the binding prevents running of any fractured filled fibres. This particularly facilitates narrow weaving or knitting where control of yarn tension is important. The binding fibres may be monofilarnent or multifilament.

Preferred yarns in accordance with this in- vention comprise less than 5% w/w of binding fibre.

The binding fibre preferably has a diameter of about 0.05 of the diameter of the bundle of filled fibres.

The binding fibre may be wound at a preferred rate of 2 to 8 turns per em, more preferably 4 to 6 turns per em, most preferably 4 turns per em. Yarn having less than 2 turns per em of wrapping fibre tend to frag- ment during weaving, whereas yarn having more than 8 turns per em is brittle and liable to break during cloth processing.

The binding fibre preferably comprises a polyester although alternative materials which form fibres having a high modulus and tensile strength may be employed.

The filled fibre preferably comprises polypropylene. Polyester fibres have also been found to be applicable. A maximum of 80% w/w of barium sulphate has been found to be appropriate although a maximum of 70% w/w may be preferred. A coupling agent may be employed, for example an alkanoyl, triisostearoyl titanate or other of the coupling agents disclosed in European patent application No.

83304777.2.

One to five binding fibres may be employed although use of a single fibre is preferred because wrapping with a plurality of fibres has not been found to confer any additional advantages. The binding fibre may be textured, bulked, crimped or otherwise treated both to impart extensibility to the yarn and to improve the ability of the yarn to withstand wet and dry fabric finishing operations.

The invention is further described by means of examples and not in any [imitative sense.

A bundles of twenty filaments composed of polypropylene (melt flow index = 12, 29.5% w/w), barium sulphate (particle size 0.5gm, 70% w/w) and a coupling agent isopropyl triisostearoyl titanate (0.5% w/w) and a pigment (Cobalt Blue Med) having a weight of not less than 3000 decitex was wrapped with 4 turns per em of a flat polyester fibre (24 filament, 74 decitex, no added lubricant). The resultant yarn contained 68% w/w of barium sulphate and satisfied both the British Pharmacopea Index test (reference SIDIV1 XVII) and the U.S. pharmaceutical X-ray opacity requirements. The yarn was found to have a minimum breaking load greater than 500 cN and a breaking extension not less than 100% but not greater than 300%. The yarn could be woven without difficulty.

Claims

1. A radio opaque yarn comprising a bundie of filled fibres containing not less than 54% w/w of barium sulphate, the bundle being bound with up to 20% w/w of substantially unfilled fibre.

2. A radio opaque yarn as claimed in claim 1, wherein the binding fibre comprises less that 5% w/w of the yarn.

3. A radio opaque yarn as claimed in any preceding claim wherein the diameter of the binding fibre is 0.05 of the diameter of the bundle of filled fibres.

4. A radio opaque yarn as claimed in any preceding claim, wherein the yarn comprises 2 to 8 turns per em of binding fibre.

5. A radio opaque yarn as claimed in claim 4, wherein the yarn comprises 4 to 6 turns per em of binding fibre.

6. A radio opaque yarn as claimed in claim 5, wherein the yarn comprises 4 turns per em of binding fibre.

7. A radio opaque yarn as claimed in any preceding claim, wherein the binding fibre comprises polyester.

8. A radio opaque yarn as claimed in any preceding claim wherein the filled fibre comprises polypropylene.

9. A radio opaque yarn as claimed in any of claims 1 to 7, wherein the filled fibre comprises polyester.

10. A radio opaque yarn as claimed in claim 8 or 9, wherein the filled fibre corn- prises 54% to 80% w/w of barium sulphate.

2 GB 2 153 867A 2

11. A radio opaque yarn as claimed in claim 10, wherein the filled fibre comprises 54% to 70% w/w of barium sulphate.

12. A radio opaque yarn as claimed in any 5 of claims 8 to 11 including an alkanoyl triisos tearoyl titanate coupling agent.

13. A radio opaque yarn substantially as hereinbefore described.

Printed in the United Kingdom for Her Majesty's Stationery Office, Dd 8818935, 1985, 4235. Published at The Patent Office, 25 Southampton Buildings, London, WC2A lAY, from which copies may be obtained.